RoosterBio Commercializes Industry’s First cGMP human Mesenchymal Stem Cell Banks for Widespread Manufacturing, Continuing to Revolutionize Regenerative Medicine. January 25, 2018
RoosterBio selects GenCure as its preferred manufacturer to leverage its scalable technology platform, accelerating the initiation of first-in-man studies. October 2, 2017
RoosterBio Launches New cGMP Stem Cell Product Portfolio, Maintaining Unwavering Commitment to Driving the Explosive Regenerative Medicine Industry. September 14, 2017
Margot Connor, CEO, RoosterBio Inc., Frederick Innovative Technology Center, Inc expected graduate earns “Top 10” Technology Industry Award. July 27, 2017
RoosterBio Launches a Xeno-Free Bioreactor Feed to Streamline Cell Expansion & Efficiently Reach Billions of hMSCs. July 6, 2017
RoosterBio Launches the Regenerative Medicine Industry’s First Xeno-Free hMSC Cell Banks to Advance and Simplify Stem Cell Biomanufacturing. May 5, 2017
Wake Forest Baptist Institute Leads Effort to Advance Manufacturing of Regenerative Medicine Therapies. March 31, 2017
RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network. January 18, 2017